WorldPingAn experimental Novartis drug for a rare neuromuscular condition failed to improve muscle function in a pivotal study…
This is a short WorldPing brief. The full report was published by STAT.
Read the full report at STATMore coverage: all health news on WorldPing.
Shares of Novartis tanked on Tuesday after results from its del-desiran drug trial disappointed investors.
Brief by WorldPing · Original reporting by CNBC World
WorldPingFor millions of Americans, Sept. 11, 2001, is a vivid memory. For younger generations, it's a history lesson.
Brief by WorldPing · Original reporting by Phys.org
WorldPingThe uplifting, award-winning show about a girl aging four times too fast electrified New York.
Brief by WorldPing · Original reporting by The Guardian
WorldPingExclusive: Staff expect ‘brutal’ cutbacks as broadcaster seeks to reduce costs amid advertising slowdown Business live – latest updates Channel 4 is poised to cut about 300 jobs – about a quarter of its workforce – in the biggest round of layoffs in…
Brief by WorldPing · Original reporting by The Guardian
The full data reinforces hopes that the drug could be a breakthrough COPD treatment and reach AstraZeneca's peak annual sales forecast of more than $5 billion.
Brief by WorldPing · Original reporting by CNBC World
WorldPingSinking of inflatable dinghy in 2021 resulted in 31 people dead or missing, including a seven-year-old child Fourteen men have gone on trial in Paris over the deaths of at least 31 people in the worst mass drowning from a small-boat crossing in the C…
Brief by WorldPing · Original reporting by The Guardian
WorldPing